Literature DB >> 12016199

Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed.

Gemma Kuijpers, Bruce Schneider, Bruce Stadel, Eric Colman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016199      PMCID: PMC1123174          DOI: 10.1136/bmj.324.7347.1218

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Recombinant human parathyroid hormone.

Authors:  Jonathan Reeve
Journal:  BMJ       Date:  2002-02-23

2.  Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).

Authors:  D Felsenberg; A J Silman; M Lunt; G Armbrecht; A A Ismail; J D Finn; W C Cockerill; D Banzer; L I Benevolenskaya; A Bhalla; J Bruges Armas; J B Cannata; C Cooper; J Dequeker; R Eastell; B Felsch; W Gowin; S Havelka; K Hoszowski; I Jajic; J Janott; O Johnell; J A Kanis; G Kragl; A Lopes Vaz; R Lorenc; G Lyritis; P Masaryk; C Matthis; T Miazgowski; G Parisi; H A P Pols; G Poor; H H Raspe; D M Reid; W Reisinger; C Schedit-Nave; J J Stepan; C J Todd; K Weber; A D Woolf; O B Yershova; J Reeve; T W O'Neill
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

3.  Epidemiology of fractures in England and Wales.

Authors:  T P van Staa; E M Dennison; H G Leufkens; C Cooper
Journal:  Bone       Date:  2001-12       Impact factor: 4.398

  3 in total
  1 in total

1.  Osteosarcoma associated with hyperparathyroidism.

Authors:  Paul C Jutte; Renato Rosso; Massimiliano de Paolis; Costatino Errani; Elisabetta Pasini; Laura Campanacci; Gaetano Bacci; Franco Bertoni; Mario Mercuri
Journal:  Skeletal Radiol       Date:  2004-05-25       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.